None listed
Conditions
Brief summary
This study is evaluating the effect of an intervention aimed at promoting earlier symptom appraisal and help-seeking for people at higher risk of lung cancer. Who is it for? You may be eligible to join this study if you are aged between 55-90 years and have smoked at least one packet of cigarettes daily for a period of 20 years (i.e. 20 pack years). This includes ex-smokers if your cessation date was less than 15 years ago. Trial details: Participants in this trial will be randomly (by chance) allocated to one of two groups. Participants in one group will receive standard care, whilst participants in the other group will be offered the CHEST intervention. This is theoretically based and comprises a 40 minute primary nurse consultation to discuss and implement a self-help manual, followed by monthly self-monitoring reminders by either, email, text message or phone call. Participants will be monitored for 12 months to evaluate the effect of the intervention on consultation rates and time to consultation for chest symptoms.
Interventions
The CHEST intervention is theoretically based and comprises a 40 minute consultation in which a nurse guides the patient through a self-help manual entitled “Chest symptoms that Call for Action”. This aims to increase the salience of chest symptoms, reinforce the benefits of and sanction early presentation, and a discussion of the barriers to presentation. A personalised action plan is developed which is reinforced through regular monthly prompts.(via email, text message or phone). In addition,
The CHEST intervention is theoretically based and comprises a 40 minute consultation in which a nurse guides the patient through a self-help manual entitled “Chest symptoms that Call for Action”. This aims to increase the salience of chest symptoms, reinforce the benefits of and sanction early presentation, and a discussion of the barriers to presentation. A personalised action plan is developed which is reinforced through regular monthly prompts.(via email, text message or phone). In addition, each patient is given a spirometry test to measure lung function. Everyone will have a questionaire posted to them to complete at three different time points in the study: at the beginning, at one month, and at 12 months. Also if the patient consults with their GP with chest symptoms during the 12 month study period they will be asked to complete a shorter "Delays" questionnaire about their symptoms. This is a self-completed questionnaire that obtains data on presenting symptoms and their duration prior to consultation. We will monitor every month during the trial the consultations of trial participants through electronic searches of the GP records.
Sponsors
University of Western Australia.
Study design
Allocation
Randomised controlled trial
Primary purpose
Prevention
Eligibility
Sex/Gender
All
Age
55 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
Aged 55 and over with at least 20 pack years, including ex-smokers if their cessation date was less than 15 years ago. Read and write English and give informed consent.
Exclusion criteria
Severe psychiatric or cognitive disorder or previous diagnosis of lung cancer.
Outcome results
None listed